Walleye Trading
GPCR icon

Walleye Trading’s Structure Therapeutics GPCR Stock Holding History

Walleye Trading’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125K Sell
2,600
-100
-4% -$6.84K ﹤0.01% 3354
2025
Q4 		$188K Sell
2,700
-23,600
-90% -$964K ﹤0.01% 3419
2025
Q3 		$736K Buy
26,300
+22,600
+611% +$450K ﹤0.01% 2472
2025
Q2 		$76.7K Hold
3,700
– – ﹤0.01% 3698
2025
Q1 		$64K Buy
3,700
+3,600
+3,600% +$88.2K ﹤0.01% 3544
2024
Q4 		$2.71K Buy
+100
New +$3.55K ﹤0.01% 4112
2024
Q3 		– Sell
-300
Closed -$11.8K – 4270
2024
Q2 		$11.8K Sell
300
-3,600
-92% -$148K ﹤0.01% 3848
2024
Q1 		$167K Sell
3,900
-20,200
-84% -$852K ﹤0.01% 3524
2023
Q4 		$982K Buy
+24,100
New +$1.38M ﹤0.01% 2479

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Walleye Trading's GPCR Position: Q1 2025 in Review

Walleye Trading sold out of Structure Therapeutics (GPCR) in Q1 2025, closing a stake of 13,485 shares — an estimated $330K sold.

Walleye Trading first reported a position in GPCR in Q4 2023 and held it in 3 quarters. The position peaked at $566K in Q4 2023. 150 funds tracked by Wall St. Rank hold GPCR as of Q1 2025.

  • Walleye Trading reported no remaining Structure Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 13,485 Structure Therapeutics shares in Q1 2025, an estimated $330K.
  • Walleye Trading first reported a position in Structure Therapeutics in Q4 2023 and held it in 3 quarters.
  • Walleye Trading's Structure Therapeutics position peaked at $566K in Q4 2023.
  • 150 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.